E-LIB Suche - Ergebnisse für: Alonso Orduña, Vicente - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

The Frequency of Specific KRAS Mutations, and Their Impact ..:

Fernández Montes, Ana ; Alonso Orduña, Vicente ; Asensio Martínez, Elena...
The Oncologist. , 2023

Link: https://doi.org/10.1093/..

2

Real-World Outcomes in Patients with Metastatic Colorectal ..:

Pericay, Carles ; Fernández Montes, Ana ; Alonso Orduña, Vicente...
Cancers. 15 (2023) 18 - p. 4603 , 2023

Link: https://doi.org/10.3390/..

3

SEOM clinical guidelines for the treatment of advanced colo..:

García-Carbonero, Rocío ; Gómez España, M. Auxiliadora ; Casado Sáenz, Enrique...
Clinical and Translational Oncology. 12 (2010) 11 - p. 729-734 , 2010

Link: https://doi.org/10.1007/..

4

Influence of hemoglobin levels on survival after radical tr..:

Valencia Julve, Javier ; Alonso Orduña, Vicente ; Escó Barón, Ricardo..
Clinical and Translational Oncology. 8 (2006) 1 - p. 22-30 , 2006

Link: https://doi.org/10.1007/..

5

Upfront primary tumour resection and survival in synchronou..:

Benavides, Manuel ; Gómez-España, Auxiliadora ; García-Alfonso, Pilar...
European Journal of Surgical Oncology. 48 (2022) 5 - p. 1123-1132 , 2022

Link: https://doi.org/10.1016/..

6

First-Line Biological Agents Plus Chemotherapy in Older Pat..:

the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) ; García-Alfonso, Pilar ; Díaz-Rubio, Eduardo...
Drugs & Aging. 38 (2021) 3 - p. 219-231 , 2021

Link: https://doi.org/10.1007/..

7

Phase II randomized trial of capecitabine with bevacizumab ..:

on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) ; Salazar, Ramón ; Capdevila, Jaume...
BMC Cancer. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

8

Phase II randomized trial of capecitabine with bevacizumab ..:

Salazar Soler, Ramón ; Capdevila, Jaume ; Manzano, José Luis...
Reproducció del document publicat a: https://doi.org/10.1186/s12885-020-07661-z. , 2020

Link: http://hdl.handle.net/24..

9

Análisis de los factores pronósticos en el cáncer de colon ..:

Hernández García, Alba ; Alonso Orduña, Vicente ; Horndler Argarete, Carlos
http://zaguan.unizar.es/record/79653. , 2018

Link: http://zaguan.unizar.es/..

10

The Role of Fluoropirimidines in Gastrointestinal Tumours: ..:

Hernando-Cubero, Jorge ; Matos-García, Ignacio ; Alonso-Orduña, Vicente.
Journal of Gastrointestinal Cancer. 48 (2017) 2 - p. 135-147 , 2017

Link: https://doi.org/10.1007/..

11

Phase II trial of induction irinotecan-cisplatin followed b..:

On Behalf of the Spanish Cooperative Group for Digestive Tumour Therapy (TTD) ; Rivera, Fernando ; Galán, Maica...
Cancer Chemotherapy and Pharmacology. 67 (2010) 1 - p. 75-82 , 2010

Link: https://doi.org/10.1007/..

12

Phase II Trial of Preoperative Irinotecan–Cisplatin Followe..:

Rivera, Fernando ; Galán, Maica ; Tabernero, Josep...
International Journal of Radiation Oncology*Biology*Physics. 75 (2009) 5 - p. 1430-1436 , 2009

Link: https://doi.org/10.1016/..

13

Real-World Outcomes in Patients with Metastatic Colorectal ..:

Carles Pericay ; Ana Fernández Montes ; Vicente Alonso Orduña...
https://www.mdpi.com/2072-6694/15/18/4603. , 2023

Link: https://doi.org/10.3390/..

14

First-Line Biological Agents Plus Chemotherapy in Older Pat..:

García-Alfonso, Pilar ; Díaz-Rubio, Eduardo ; Abad, Albert...
http://hdl.handle.net/10668/17214. , 2021

Link: http://hdl.handle.net/10..

15

VITAL phase 2 study : Upfront 5-fluorouracil, mitomycin-C, ..:

Feliu, Jaime ; Garcia-Carbonero, Rocio ; Capdevila, J...
Cancer Medicine. , 2020

Link: https://ddd.uab.cat/reco..

1-15